IE43702B1 - E.coli enterotoxin purification - Google Patents

E.coli enterotoxin purification

Info

Publication number
IE43702B1
IE43702B1 IE2352/75A IE235275A IE43702B1 IE 43702 B1 IE43702 B1 IE 43702B1 IE 2352/75 A IE2352/75 A IE 2352/75A IE 235275 A IE235275 A IE 235275A IE 43702 B1 IE43702 B1 IE 43702B1
Authority
IE
Ireland
Prior art keywords
coli
enterotoxin
buffer
gel
purified
Prior art date
Application number
IE2352/75A
Other languages
English (en)
Other versions
IE43702L (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1467174A external-priority patent/CH612994A5/de
Priority claimed from CH604075A external-priority patent/CH615196A5/de
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE43702L publication Critical patent/IE43702L/xx
Publication of IE43702B1 publication Critical patent/IE43702B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IE2352/75A 1974-11-01 1975-10-29 E.coli enterotoxin purification IE43702B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1467174A CH612994A5 (en) 1974-11-01 1974-11-01 Process for the preparation of coli enterotoxin
CH1645874 1974-12-11
CH1645974 1974-12-11
CH604075A CH615196A5 (en) 1975-05-12 1975-05-12 Purification process for coli enterotoxin

Publications (2)

Publication Number Publication Date
IE43702L IE43702L (en) 1976-05-01
IE43702B1 true IE43702B1 (en) 1981-05-06

Family

ID=27428963

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2352/75A IE43702B1 (en) 1974-11-01 1975-10-29 E.coli enterotoxin purification

Country Status (16)

Country Link
JP (1) JPS5170810A (enrdf_load_stackoverflow)
AU (1) AU511934B2 (enrdf_load_stackoverflow)
CA (1) CA1053152A (enrdf_load_stackoverflow)
DD (1) DD124879A5 (enrdf_load_stackoverflow)
DE (1) DE2547224A1 (enrdf_load_stackoverflow)
DK (2) DK478575A (enrdf_load_stackoverflow)
ES (1) ES442242A1 (enrdf_load_stackoverflow)
FI (2) FI752964A7 (enrdf_load_stackoverflow)
FR (1) FR2289206A1 (enrdf_load_stackoverflow)
GB (1) GB1529871A (enrdf_load_stackoverflow)
IE (1) IE43702B1 (enrdf_load_stackoverflow)
IL (1) IL48384A (enrdf_load_stackoverflow)
NL (1) NL7512590A (enrdf_load_stackoverflow)
NO (1) NO753578L (enrdf_load_stackoverflow)
NZ (1) NZ179108A (enrdf_load_stackoverflow)
SE (1) SE8100404L (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740585A (en) * 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738364B (en) * 1972-12-04 1974-09-25 Rit Rech Ind Therapeut Piglet colibacillosis vaccines and process for their preparation

Also Published As

Publication number Publication date
FI752964A7 (enrdf_load_stackoverflow) 1976-05-02
NO753578L (enrdf_load_stackoverflow) 1976-05-04
DK278478A (da) 1978-06-20
IE43702L (en) 1976-05-01
FR2289206B1 (enrdf_load_stackoverflow) 1978-11-10
SE8100404L (sv) 1981-01-23
IL48384A0 (en) 1976-03-31
FR2289206A1 (fr) 1976-05-28
DD124879A5 (enrdf_load_stackoverflow) 1977-03-16
CA1053152A (en) 1979-04-24
AU8628275A (en) 1977-05-12
IL48384A (en) 1979-05-31
DE2547224A1 (de) 1976-05-13
GB1529871A (en) 1978-10-25
NZ179108A (en) 1978-07-28
FI782827A7 (fi) 1978-09-14
ES442242A1 (es) 1977-08-01
DK478575A (da) 1976-05-02
NL7512590A (en) 1976-05-04
JPS5170810A (enrdf_load_stackoverflow) 1976-06-18
AU511934B2 (en) 1980-09-11

Similar Documents

Publication Publication Date Title
Alderete et al. Purification and chemical characterization of the heat-stable enterotoxin produced by porcine strains of enterotoxigenic Escherichia coli
Daniel et al. Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties
Une et al. Roles of V antigen in promoting virulence and immunity in yersiniae.
Kunkel et al. Purification and chemical characterization of the heat-labile enterotoxin produced by enterotoxigenic Escherichia coli
Finkelstein et al. Pathogenesis of experimental cholera: preparation and isolation of choleragen and choleragenoid
Lai et al. The Chemistry and Biology of Cholera Toxi
JPS58222033A (ja) Ｄｎａ配列、組換えｄｎａ、コレラ毒素のサブユニツトａおよびｂ、および該サブユニツト含有製剤
JPS60501689A (ja) 連鎖球菌ｍ蛋白質遺伝子及びその分子状プローブ
Riezu-Boj et al. Comparison of lipopolysaccharide and outer membrane protein-lipopolysaccharide extracts in an enzyme-linked immunosorbent assay for the diagnosis of Brucella ovis infection
US5043158A (en) Immunogenic compositions containing ordered carriers
Chang et al. Purification and some physicochemical properties of staphylococcal enterotoxin D
US4314993A (en) Immunogenic E. coli ST enterotoxin derivatives and compositions containing them
US4220584A (en) E. coli enterotoxin vaccine for veterinary and human use
Domer et al. Escherichia coli enterotoxin: purification, partial characterization, and immunological observations
IE43702B1 (en) E.coli enterotoxin purification
Kapitany et al. Isolation and partial characterization of two different heat-stable enterotoxins produced by bovine and porcine strains of enterotoxigenic Escherichia coli
Dorner et al. Escherichia coli enterotoxin: stimulation of adenylate cyclase in broken-cell preparations
Stewart et al. Cross‐protection from Bacteroides nodosus vaccines and the interaction of pili and adjuvants
Stemshorn et al. The bovine immune response to Brucella abortus I. A water soluble antigen precipitated by sera of some naturally infected cattle
Lopez-Merino et al. Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances
EP0145486A2 (en) Microbiological process
US4545931A (en) Synthetic heat-stable enterotoxin polypeptide of Escherichia coli
CN100406472C (zh) 一种眼镜蛇神经毒素蛋白的融合可溶表达、重组毒素的酸解释放及其生产纯化方法
Kabir Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation
Lemcke et al. IMMUNOCHEMICAL ANALYSIS OF MYCOPLASMA PNEUMONIAE: 2. PROPERTIES OF CHLOROFORM METHANOL EXTRACT FROM M. PNEUMONIAE